Background: Cardiomyocytes exit the cell cycle postnatally and the adult heart possesses only
a very limited regenerative capacity. The question of why cardiomyocytes lose their
regenerative potential is unanswered. One explanation could be the continuous need
for work that precludes cell division. We generated human pluripotent stem cell-derived
cardiomyocytes (CM), in which contractility could be inhibited reversible with small
molecules, to assess this hypothesis experimentally.
Methods: A pharmacological selective actuator module (PSAM), consisting of a modified nicotinergic
acetylcholine receptor and the ion pore domain of the glycine receptor (PSAM-GlyR)
was integrated in the AAVS1-locus of induced pluripotent stem cells (iPSC). PSAM-GlyR
iPSC were differentiated to CM. CM were cast into three-dimensional engineered heart
tissue (EHT). Force and frequency were measured by video-optical analysis. Troponin
I concentration was measured in the supernatant to assess sarcomere turnover. EHTs
were harvested on day 21 and 49 of culture and processed for histology. Cell cycle
activity was assessed histologically by Ki67 staining.
Results: PSAM-GlyR EHT started to beat after 6 days in culture. In the intervention groups
PSEM89S was applied from the beginning of culture either for 21 or for 49 days. Activation
with the small molecular pharmacologically selective effector molecule 89S (PSEM89S)
resulted in a depolarization block and PSA-GlyR EHT in the intervention groups did
not start to beat. Yet, all EHT developed morphologically similar irrespective of
beating. Troponin I concentration was lower in the medium of EHT that did not beat
(day 21: 7.8 ± 0.5 pg/mL vs. 119.3 ± 17.0 pg/mL, day 49: 15.3± 0.9 pg/mL vs. 297.2 ± 203.3
pg/mL). In accordance sarcomere organization was lower in these EHT. After PSEM89S
wash-out EHTs started to beat within 120 minutes on day 21 or 49 respectively. After
7 days they developed similar forces as the time-matched controls. Troponin concentration
increased in the media after the EHT started to beat (99.9 ± 36.6 pg/mL). There was
no difference in Ki67 positive nuclei at day 21 (beating control: 10.2 ± 0.5% vs.
stopped: 13.8 ± 3.5%). However, cell cycle activity decreased in the beating controls
over time (6.3 ± 1.9% at day 49). In contrast it remained higher in the PSAM-GlyR
EHT that did not beat (12.1 ± 1.4%).
Conclusion: Inhibition of cardiac contractility prevented sarcomere assembly and resulted in
higher cell cycle activity, providing first evidence that cardiac work inhibits cell
cycle activity.